[HTML][HTML] Genome-wide association study of Alzheimer's disease brain imaging biomarkers and neuropsychological phenotypes in the European medical information …

J Homann, T Osburg, O Ohlei, V Dobricic… - Frontiers in aging …, 2022 - frontiersin.org
Alzheimer’s disease (AD) is the most frequent neurodegenerative disease with an increasing
prevalence in industrialized, ageing populations. AD susceptibility has an established …

TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

S Hong, V Dobricic, O Ohlei, I Bos… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction Neurofilament light (NfL), chitinase‐3‐like protein 1 (YKL‐40), and neurogranin
(Ng) are biomarkers for Alzheimer's disease (AD) to monitor axonal damage, astroglial …

Critical evaluation of the DNA-methylation markers ABCG1 and SREBF1 for Type 2 diabetes stratification

…, M Grohs, AT El Gammal, S Wolter, O Ohlei… - …, 2019 - Future Medicine
Aim: Validation of epigenome-wide association studies is sparse. Therefore, we evaluated
the methylation markers cg06500161 (ABCG1) and cg11024682 (SREBF1) as classifiers for …

Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains

…, M Schilling, I Farkas, DO Gveric, O Ohlei… - Brain …, 2022 - academic.oup.com
Dysregulation of microRNA gene expression has been implicated in many neurodegenerative
diseases, including Parkinson’s disease. However, the individual dysregulated …

In situ detection of PR3-ANCA+ B cells and alterations in the variable region of immunoglobulin genes support a role of inflamed tissue in the emergence of auto …

G Weppner, O Ohlei, CM Hammers, K Holl-Ulrich… - Journal of …, 2018 - Elsevier
Circulating anti-neutrophilic cytoplasmic autoantibodies targeting proteinase 3 (PR3-ANCA)
are a diagnostic and pathogenic hallmark of granulomatosis with polyangiitis (GPA). It is, …

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

A Neumann, O Ohlei, F Küçükali, IJ Bos, J Timsina… - Genome medicine, 2023 - Springer
Background Genome-wide association studies (GWAS) of Alzheimer’s disease (AD) have
identified several risk loci, but many remain unknown. Cerebrospinal fluid (CSF) biomarkers …

Epigenome-wide association study in peripheral tissues highlights DNA methylation profiles associated with episodic memory performance in humans

Y Sommerer, V Dobricic, M Schilling, O Ohlei… - Biomedicines, 2022 - mdpi.com
The decline in episodic memory (EM) performance is a hallmark of cognitive aging and an
early clinical sign in Alzheimer’s disease (AD). In this study, we conducted an epigenome-…

Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease

Y Sommerer, V Dobricic, M Schilling, O Ohlei… - Alzheimer's Research & …, 2023 - Springer
Background Studies on DNA methylation (DNAm) in Alzheimer’s disease (AD) have recently
highlighted several genomic loci showing association with disease onset and progression. …

Field synopsis and systematic meta-analyses of genetic association studies in isolated dystonia

O Ohlei, V Dobricic, K Lohmann, C Klein, CM Lill… - Parkinsonism & Related …, 2018 - Elsevier
Background and objectives Dystonia is a genetically complex disease with both monogenic
and polygenic causes. For the latter, numerous genetic associations studies have been …

Genome-wide meta-analysis of short-tandem repeats for Parkinson's disease risk using genotype imputation

O Ohlei, K Paul, S Searles Nielsen… - Brain …, 2024 - academic.oup.com
Idiopathic Parkinson’s disease is determined by a combination of genetic and environmental
factors. Recently, the first genome-wide association study on short-tandem repeats in …